- Also known as
- Semax Selank blend · Selank + Semax · Semax/Selank 20 mg
- Class
- Two-peptide research blend (ACTH(4-10) analogue + tuftsin analogue)
- Form
- Lyophilised powder supplied in 20 mg vials
- Sizes
- 20 mg
- Storage, dry
- −20 °C, dry and dark
- Storage, mixed
- 2–8 °C, use within 28 days of mixing (as generally reported for reconstituted peptides)
- BAC water per size
- 20 mg: 3 mL
What is Semax + Selank?
Semax + Selank ships as a single vial of lyophilised powder containing Semax 10 mg and Selank 10 mg. The two compounds carry separate literatures, and the references gathered here are those separate studies. Its recorded sequences are Semax 10 mg (Met-Glu-His-Phe-Pro-Gly-Pro) and Selank 10 mg (Thr-Lys-Pro-Arg-Pro-Gly-Pro), both ending in Pro-Gly-Pro. The published record covers human, mouse and in-vitro enzyme assay work. Of the 8 references below, 4 are controlled human trials. It comes as lyophilised powder in 20 mg vials, kept in Canadian stock for laboratory research. None of it is a medicine; it is not for human or veterinary use.
What the research shows
| Study | Model | Dose used | Duration | Finding |
|---|---|---|---|---|
| Gusev EI et al.2018 · Zh Nevrol Psikhiatr Im S S Korsakova · PMID 29798983 | Human, controlled clinical study, ischaemic stroke rehabilitation (n=110) | 6000 mcg/day | Two 10-day courses with a 20-day interval | Semax raised plasma BDNF, which stayed high through the study, regardless of when rehabilitation started. Semax and high BDNF were associated with faster improvement and a better final Barthel index score. |
| Gusev EI et al.1997 · Zh Nevrol Psikhiatr Im S S Korsakova · PMID 11517472 | Human, controlled clinical trial, acute hemispheric ischaemic stroke (n=30 Semax, 80 conventional-therapy controls) | 12 mg/day (moderate stroke) and 18 mg/day (severe stroke) were reported as the most effective daily doses | 5- and 10-day courses | Adding Semax to standard intensive therapy had some influence on the rate of recovery of neurological function, particularly motor deficits, assessed with clinical scales, EEG mapping and somatosensory evoked potentials. |
| Lebedeva IS et al.2018 · Bull Exp Biol Med · PMID 30225715 | Human, placebo-controlled resting-state fMRI study in healthy volunteers (n=24: 14 Semax, 10 placebo) | Intranasal 1% Semax (volume not stated in the abstract) | Single administration; scans before and 5 and 20 min after | The Semax group showed a greater volume of the rostral (medial frontal cortex) subcomponent of the default mode network than the placebo group. |
| Zozulia AA et al.2008 · Zh Nevrol Psikhiatr Im S S Korsakova · PMID 18454096 | Human, randomised controlled trial, generalised anxiety disorder and neurasthenia (n=62: 30 Selank, 32 medazepam) | Not stated in the abstract | Not stated in the abstract | Anxiolytic effects of Selank and medazepam were similar on Hamilton, Zung and CGI scales, and Selank also showed anti-asthenic and psychostimulant effects. Serum leu-enkephalin half-life, low at baseline, rose during Selank treatment, mostly in patients with GAD. |
| Medvedev VE et al.2015 · Zh Nevrol Psikhiatr Im S S Korsakova · PMID 26356395 | Human, randomised controlled trial, anxiety disorders (n=70: 30 phenazepam alone, 40 Selank plus phenazepam) | Not stated in the abstract | Not stated in the abstract | Adding Selank brought on the effect of phenazepam earlier on the HDRS and reduced phenazepam side effects such as attention and memory impairment, sedation and asthenia. Quality of life on the SF-36 improved. |
| Panikratova YR et al.2020 · Dokl Biol Sci · PMID 32342318 | Human, placebo-controlled resting-state fMRI study in healthy participants (n=52); separate Semax, Selank and placebo groups | Not stated in the abstract | Single administration; scans before and 5 and 20 min after | Differences were found in connectivity between the right amygdala and the right temporal cortex, with both general and specific effects of Selank and Semax. Each participant received one peptide or placebo, not both. |
| Kost NV et al.2001 · Bioorg Khim · PMID 11443939 | Enzyme assay in vitro (enkephalin-degrading enzymes from human serum); Semax and Selank tested separately | Dose-dependent; IC50 10 µM for Semax and 20 µM for Selank | Not applicable (enzyme assay) | Both heptapeptides inhibited the enkephalin-degrading enzymes of human serum more strongly than puromycin (IC50 10 mM) and bacitracin. Their pentapeptide fragments also inhibited the enzymes; tri-, tetra- and hexapeptide fragments did not. |
| Sokolov OY et al.2002 · Bull Exp Biol Med · PMID 12432865 | Mouse (BALB/c and C57Bl/6), open-field test and plasma enzyme assay | 100 mcg/kg | Not stated in the abstract | Selank had an anxiolytic effect in the open-field test and lengthened plasma leu-enkephalin half-life in BALB/c mice, with no effect on behaviour or enkephalinase activity in C57Bl/6 mice. |
What these studies don't show: Controlled human data does exist, though its scope is limited. Hand-picked groups and surrogate endpoints cap how far the findings can carry. Safety beyond those trial conditions is still unestablished. Knowing the vial contains what the label states is not the same as knowing the compound does anything.
Every study links to its PubMed record. See all Semax + Selank studies in the research library →
Semax + Selank price in Canada: 20mg vial
Buy Semax + Selank in Canada in a 20mg vial. Prices are in Canadian dollars, you pay by Interac e-Transfer or bank transfer, and orders are shipped from Canadian stock.
| Size | Price | Per mg |
|---|---|---|
| 20 mg | $95.00 | $4.75/mg |
Is Semax + Selank available in Canada?
There is no authorized Semax + Selank product in Canada: no DIN has been issued for it. Health Canada has reached no finding on it, since it has never been submitted for one. Borealis Peptides keeps it solely for in-vitro research, provided for use in no living subject. How Health Canada treats research peptides →
Side effects reported in studies
Every statement here is linked to the study that recorded it. Tolerability observations from the cited papers appear below in the authors' own words. Human work on this scale does not establish a safety profile.
Semax + Selank FAQ
What is Semax + Selank?
Semax + Selank is a two-peptide research blend (ACTH(4-10) analogue + tuftsin analogue). Its published record is drawn from human, mouse and in-vitro enzyme assay work. Borealis Peptides provides it as lyophilised powder in 20 mg vials for in-vitro laboratory research. None of it is a medicine; it is not for human or veterinary use. The table on this page sets out each study, its model and its reported result.
Where can I buy Semax + Selank in Canada?
It is dispatched within Canada from the stock we keep, in 20 mg vials. Nothing goes out without HPLC confirmation of identity and purity for that batch. Borealis Peptides takes research orders only and ships to research and business addresses. Identity and purity are checked per batch, and the paperwork names that specific batch.
Is Semax + Selank legal in Canada?
There is no authorized Semax + Selank product in Canada: no DIN has been issued for it. Health Canada has reached no finding on it, since it has never been submitted for one. Borealis Peptides keeps it strictly for in-vitro research and provides it for no use in a living subject. Health Canada has stated that "Research Use Only" labelling does not make a product legal to use in a person, so we read it strictly as a statement of what the material is for, not an authorisation.
How much Semax + Selank should I use?
There is nothing to give. This site holds no protocol, no schedule and no reconstitution volume. The quantities in the cited studies belong to those studies and the models they ran in; they appear so that the evidence can be weighed rather than accepted on trust.
What human evidence is there for Semax + Selank?
Of the 8 cited studies, 4 are controlled trials in people and the rest are animal or cell work. Each row lists its model, the amount used and the authors' reported outcome, so every study can be weighed on its own terms instead of through a summary.
Does Semax + Selank need refrigeration?
Unopened, keep it at −20 °C in the dark. In solution it sits at 2–8 °C. The dry form is stable at room temperature, so no cold chain is needed in transit; refrigerate on arrival. A lyophilised peptide is degraded by light and temperature cycling rather than by how long it spends shipping.
How is the purity of Semax + Selank confirmed?
HPLC testing is done on every batch before sale, and the certificate points to the batch in your vial rather than to the product as a whole. Holding on to that batch number alongside your records is what lets an observation be reproduced later. Certificates can be supplied on request.
How does Semax + Selank compare with Semax and Selank?
Each carries its own published record, and comparing them comes down to reading both. Semax and Selank have 8 cited studies and 8 cited studies on their page against 8 here. Place the two evidence tables side by side and the difference shows plainly.
Why is Semax + Selank named in a Health Canada advisory?
Because it was one of the peptides seized from sellers offering unauthorized injectable products online. That advisory deals with material sold for people to inject without authorization. All Borealis Peptides supplies is research material for the laboratory, never anything for injection or for any use in a person, and the advisory draws its line on exactly that point.






